Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application

Detalles Bibliográficos
Autores principales: Sadremomtaz, Afsaneh, Ali, Ameena M., Jouyandeh, Foroozan, Balalaie, Saeed, Navari, Razieh, Broussy, Sylvain, Mansouri, Kamran, Groves, Matthew R., Asghari, S. Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272640/
https://www.ncbi.nlm.nih.gov/pubmed/32499505
http://dx.doi.org/10.1038/s41392-020-0177-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272640/
https://www.ncbi.nlm.nih.gov/pubmed/32499505
http://dx.doi.org/10.1038/s41392-020-0177-z

Ejemplares similares